Bio-Rad Laboratories (BIO) Other Accumulated Expenses (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Other Accumulated Expenses of $153.9 million for Q1 2026, up 16.86% year-over-year from $131.7 million in Q1 2025, and up 8.61% quarter-over-quarter from $141.7 million in Q4 2025.
Bio-Rad Laboratories (BIO) Other Accumulated Expenses (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Other Accumulated Expenses for 18 consecutive years, with $153.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Accumulated Expenses rose 16.86% year-over-year to $153.9 million; the TTM figure through Mar 2026 stood at $153.9 million (up 16.86% YoY), while the FY2025 annual figure was $141.7 million, down 3.74% from the prior year.
- Other Accumulated Expenses advanced to $153.9 million in Q1 2026 per BIO's latest filing, from $141.7 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $212.7 million in Q2 2022 and bottomed at $127.8 million in Q3 2025.
- Historically, Other Accumulated Expenses has averaged $160.0 million across 5 years, with a median of $153.9 million in 2026.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses surged 371.51% — and 2023, when it decreased 21.85%.
- Bio-Rad Laboratories' Other Accumulated Expenses stood at $169.6 million in 2022, then dropped by 4.74% to $161.6 million in 2023, then fell by 8.91% to $147.2 million in 2024, then retreated by 3.74% to $141.7 million in 2025, then climbed by 8.61% to $153.9 million in 2026.
- Business Quant data shows BIO's Other Accumulated Expenses at $153.9 million in Q1 2026, $141.7 million in Q4 2025, and $127.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Bio-Rad Laboratories | 10.08 Bn | 8.46 Bn | 345.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 158.80 Mn |
| Mar 31, 2026 | 153.90 Mn |
| Dec 31, 2025 | 141.70 Mn |
| Sep 30, 2025 | 127.80 Mn |
| Jun 30, 2025 | 175.00 Mn |
| Mar 31, 2025 | 131.70 Mn |
| Dec 31, 2024 | 147.20 Mn |
| Sep 30, 2024 | 142.01 Mn |
| Jun 30, 2024 | 149.92 Mn |
| Mar 31, 2024 | 142.43 Mn |
| Dec 31, 2023 | 161.60 Mn |
| Sep 30, 2023 | 147.80 Mn |
| Jun 30, 2023 | 166.24 Mn |
| Mar 31, 2023 | 167.20 Mn |
| Dec 31, 2022 | 169.65 Mn |
| Sep 30, 2022 | 171.71 Mn |
| Jun 30, 2022 | 212.72 Mn |
| Mar 31, 2022 | 211.59 Mn |
| Dec 31, 2021 | 35.98 Mn |
| Sep 30, 2021 | 177.72 Mn |